AusBiotech opens call for sessions for Brisbane's 2027 'Biggest Week in Biotech'

AusBiotech

AusBiotech has opened its call for session proposals for Australia's Biggest Week in Biotech 2027, which will be held in Brisbane from 23 to 27 August next year. Proposals close on Friday 19 February 2027.

The call covers the program for three events held during the week. These are the AusBiotech International Conference, the AusMedtech Conference and the AusBiotech Investment Conference. AusBiotech is inviting industry leaders, innovators, investors, researchers and experts to contribute. The organisation says it is looking for "more submissions than ever before."

The 2027 theme is 'Where Ambition Connects'.

AusBiotech wants content that is engaging, commercially relevant, and forward-looking, with an emphasis on international engagement and industry growth. Its stated areas of interest range from emerging technologies in biotechnology, medtech, and healthtech to global partnerships, investment, commercialisation, and sector growth.

Each conference has its own focus.

The AusBiotech International Conference is seeking content on industry challenges, emerging opportunities, commercialisation, global partnerships, innovation, and the growth of Australia's biotechnology ecosystem.

AusMedtech wants industry perspectives and practical insights into the challenges and opportunities facing medical technology companies, including regulatory developments and investment.

The investment conference seeks perspectives on investment trends, access to capital, commercialisation strategies, and how Australian life sciences companies can scale and compete internationally.

AusBiotech has listed seven program priorities and says they are a guide, not a limit. They are global partnering and collaboration, investment and capital pathways, scaling Australian innovation globally, and medtech, diagnostics and digital health. The other three are regulatory, policy and market access, manufacturing, supply chains and sovereign capability, and emerging technologies with global application.

The regulatory and market access stream invites proposals on domestic and international regulation, reimbursement, health technology assessment and health system access across therapeutics, devices, diagnostics and digital health. It also covers policy settings that support global competitiveness. The medtech stream includes clinical validation, procurement, adoption and AI-enabled technologies. The manufacturing stream asks about supply chain resilience and Australia's role in regional and global manufacturing.

Proposals can be for presentations, panel discussions, workshops or other formats. Each submission needs a session title and a description of no more than 120 words covering the topic, key discussion points and intended outcomes. It must also explain why the topic matters to the sector and who would benefit from attending, and give the names, positions, organisations and relevant expertise of suggested speakers.

Reviewers will look for industry relevance, originality, practical application, strong speakers, and clarity and completeness. AusBiotech encourages early submissions and says it will review proposals as they arrive.

AusBiotech says submitting a proposal does not guarantee a place in the program (submit here). It may contact submitters about content, speakers or format. It may also refine or combine proposals and invite more contributors to build a balanced program. AusBiotech makes the final programming decisions.